Medical Devices - LATAM

LATAM

Highlights

The Medical Devices market market in LATAM is forecasted to achieve a revenue of US$38.10bn by 2024.
Among the markets, Cardiology_Devices is expected to be the largest, with a projected market volume of US$6.01bn in 2024.
The market is anticipated to display a Compound Annual Growth Rate (CAGR 2024-2029) of 5.84%, leading to a market volume of US$50.60bn by 2029.
In terms of global comparison, the United States is expected to generate the highest revenue, amounting to US$181.00bn in 2024.
The demand for medical devices in LATAM is rapidly increasing due to the region's growing healthcare infrastructure and rising population.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Medical Devices market in LATAM is experiencing significant growth and development due to various factors.

Customer preferences: Customers in LATAM have shown a strong preference for technologically advanced medical devices that offer accurate and efficient diagnosis and treatment. They are increasingly seeking devices that are user-friendly and can be easily integrated into existing healthcare systems. Additionally, customers in this region are becoming more conscious of the cost of healthcare and are demanding affordable medical devices that provide value for money.

Trends in the market: One of the key trends in the Medical Devices market in LATAM is the increasing adoption of telemedicine and remote patient monitoring devices. This trend is driven by the need to provide healthcare services to remote and underserved areas, as well as the growing aging population in the region. Telemedicine and remote patient monitoring devices enable healthcare professionals to remotely monitor patients' vital signs and provide timely medical intervention, reducing the need for in-person visits and improving access to healthcare. Another trend in the market is the growing demand for minimally invasive surgical devices. These devices offer several advantages over traditional surgical procedures, including shorter recovery times, reduced risk of infection, and less scarring. The adoption of minimally invasive surgical devices is driven by the desire to improve patient outcomes and reduce healthcare costs.

Local special circumstances: The Medical Devices market in LATAM is influenced by several local special circumstances. One of these is the presence of a large uninsured population in many countries in the region. This creates a demand for affordable medical devices that can be used in low-resource settings and provide access to healthcare for underserved populations. Another local special circumstance is the regulatory environment in LATAM. Each country in the region has its own set of regulations and approval processes for medical devices. This can create challenges for manufacturers and distributors who want to enter multiple markets in the region. However, efforts are being made to harmonize regulations across countries in LATAM to facilitate trade and improve access to medical devices.

Underlying macroeconomic factors: The growth of the Medical Devices market in LATAM is also influenced by underlying macroeconomic factors. Economic growth and rising disposable incomes in the region have led to an increase in healthcare spending. This has created opportunities for market players to introduce innovative medical devices and expand their presence in the region. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, in LATAM is driving the demand for medical devices. These devices are essential for the diagnosis, treatment, and management of these conditions. As the burden of chronic diseases continues to rise, the demand for medical devices is expected to grow further. In conclusion, the Medical Devices market in LATAM is experiencing growth and development driven by customer preferences for technologically advanced and affordable devices, trends such as the adoption of telemedicine and minimally invasive surgical devices, local special circumstances including the presence of a large uninsured population and regulatory challenges, and underlying macroeconomic factors such as economic growth and the increasing prevalence of chronic diseases.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.